Clinical Trial Update: Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating modafinil versus placebo for hypoactive delirium in critically ill patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Respiratory Failure

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Delirium, Respiratory Failure | Phase 3 | Status: WITHDRAWN